Nothing Special   »   [go: up one dir, main page]

Atloo et al., 2022 - Google Patents

The Bovine Serum Albumin Coated Copper Oxide Nanoparticle for Curcumin Delivery in Biological Environment: In-vitro Drug Release

Atloo et al., 2022

View PDF
Document ID
16247129177357074917
Author
Atloo T
Mohammadkhani R
Mohammadi A
Zaboli K
Kaboli S
Rahimi H
Nosrati H
Danafar H
Publication year
Publication venue
Journal of Polymers and the Environment

External Links

Snippet

The copper oxide nanoparticles (CuO NPs) were synthesized by a simple method and then coated with the bovine serum albumin (BSA) to form CuO@ BSA NPs. Finally, curcumin (CUR) as an anticancer drug was loaded to the CuO@ BSA NPs. The characterization of …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5146Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48876Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions

Similar Documents

Publication Publication Date Title
Guo et al. Modular assembly of biomaterials using polyphenols as building blocks
Qiang et al. A novel macrophage-mediated biomimetic delivery system with NIR-triggered release for prostate cancer therapy
Shen et al. Fe3O4 nanoparticles in targeted drug/gene delivery systems
Wei et al. Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy
Venkatasubbu et al. Folate targeted PEGylated titanium dioxide nanoparticles as a nanocarrier for targeted paclitaxel drug delivery
Ayyanaar et al. ROS-responsive chitosan coated magnetic iron oxide nanoparticles as potential vehicles for targeted drug delivery in cancer therapy
Li et al. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy
Sabzini et al. Development of chitosan/halloysite/graphitic‑carbon nitride nanovehicle for targeted delivery of quercetin to enhance its limitation in cancer therapy: An in vitro cytotoxicity against MCF-7 cells
Shakil et al. In vivo toxicity studies of chitosan-coated cobalt ferrite nanocomplex for its application as MRI contrast dye
Ruman et al. Synthesis and characterization of chitosan-based nanodelivery systems to enhance the anticancer effect of sorafenib drug in hepatocellular carcinoma and colorectal adenocarcinoma cells
Figueroa et al. Design and characterization of chitosan-graphene oxide nanocomposites for the delivery of proanthocyanidins
Li et al. Supramolecular assembly of protein-based nanoparticles based on tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) for cancer therapy
Rahimi et al. Needle-shaped amphoteric calix [4] arene as a magnetic nanocarrier for simultaneous delivery of anticancer drugs to the breast cancer cells
Bruckmann et al. Biological applications of silica-based nanoparticles
Tarantash et al. Preparation, characterization and in vitro anticancer activity of paclitaxel conjugated magnetic nanoparticles
Lee et al. Mannosylated poly (acrylic acid)-coated mesoporous silica nanoparticles for anticancer therapy
Zarepour et al. Fabricating β-cyclodextrin based pH-responsive nanotheranostics as a programmable polymeric nanocapsule for simultaneous diagnosis and therapy
Ajith et al. Nanoparticle-based materials in anticancer drug delivery: Current and future prospects
Atloo et al. The Bovine Serum Albumin Coated Copper Oxide Nanoparticle for Curcumin Delivery in Biological Environment: In-vitro Drug Release
Pooresmaeil et al. Metal-organic framework/carboxymethyl starch/graphene quantum dots ternary hybrid as a pH sensitive anticancer drug carrier for co-delivery of curcumin and doxorubicin
Bayat et al. Improving release profile and anticancer activity of 5-fluorouracil for breast cancer therapy using a double drug delivery system: chitosan/agarose/γ-alumina nanocomposite@ double emulsion
Nabipour et al. Sustainable drug delivery systems through green nanotechnology
Li et al. A Review of Cyclodextrin Encapsulation and Intelligent Response for the Release of Curcumin
Mi et al. Preparation of doxorubicin-loaded carboxymethyl-β-cyclodextrin/chitosan nanoparticles with antioxidant, antitumor activities and pH-sensitive release
Hemmati et al. In vitro evaluation of curcumin-loaded chitosan-coated hydroxyapatite nanocarriers as a potential system for effective treatment of cancer